LoginRegister
    Saracatinib gets Orphan Drug Designation for idiopathic pulmonary fibrosisSaracatinib gets Orphan Drug Designation for idiopathic pulmonary fibrosis
    FDA approves new device for treating moderate to severe chronic heart failure in patientsFDA approves new device for treating moderate to severe chronic heart failure in patients
    Interim Relief: Delhi High Court stays ban on e-cigarettes,Vapes,E-Sheesha till May 17, 2019Interim Relief: Delhi High Court stays ban on e-cigarettes,Vapes,E-Sheesha till May 17, 2019
    Alkem Labs gets 8 USFDA observations for St Louis facilityAlkem Labs gets 8 USFDA observations for St Louis facility
    Setback: USFDA rejects Sanofi, Lexicon Sotagliflozin for type 1 diabetesSetback: USFDA rejects Sanofi, Lexicon Sotagliflozin for type 1 diabetes
    Smiths Group to list struggling healthcare unitSmiths Group to list struggling healthcare unit
    Jury finding upends Bayer Roundup defense strategy-ExpertsJury finding upends Bayer Roundup defense strategy-Experts
    NATHEALTH appoints Manipal Health Enterprise Chairman Dr Sudarshan Ballal as president for 2019-20NATHEALTH appoints Manipal Health Enterprise Chairman Dr Sudarshan Ballal as president for 2019-20
    Sterling Biotech: Accused in Rs 8100 crore loan fraud held in AlbaniaSterling Biotech: Accused in Rs 8100 crore loan fraud held in Albania
    Alembic Pharma gets USFDA nod for Azelastine Hydrochloride Ophthalmic SolutionAlembic Pharma gets USFDA nod for Azelastine Hydrochloride Ophthalmic Solution
    Syngene International wins CMO Leadership AwardsSyngene International wins CMO Leadership Awards
    Stop promotion of tobacco brands in Filmfare Awards: Delhi Government Official to CentreStop promotion of tobacco brands in Filmfare Awards: Delhi Government Official to Centre
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X